New perspectives on Glutamate Receptor Antagonists as Antidepressants

被引：10
|
作者：
Chung, ChiHye [1 ]
机构：
[1] Konkuk Univ, Dept Biol Sci, Seoul 143701, South Korea
来源：
ARCHIVES OF PHARMACAL RESEARCH | 2012年 / 35卷 / 04期
关键词：
MAJOR DEPRESSIVE DISORDER; D-ASPARTATE ANTAGONIST; MOOD DISORDERS; ACID RECEPTORS; FORCED SWIM; NMDA; KETAMINE; STRESS; EPIDEMIOLOGY; PHARMACOLOGY;
D O I：
10.1007/s12272-012-0400-8
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Classical antidepressants elevate the monoamine levels in the brain by preventing re-uptake of monoamines after release. Treatment of depression with monoamine re-uptake inhibitors is associated with low clinical efficacy and remission rate due to the delayed onset of therapeutic responses. Therefore, the development of alternative antidepressants is essential for successful treatment of this disease. Recently, glutamate receptor antagonists including ketamine and 2-methyl-6-(phenylethynyl)-pyridine (MPEP) have received wide attention as fast-acting therapeutic alternatives for treatment of depression.
引用
收藏
页码：573 / 577
页数：5
相关论文
共 50 条
  • [31] New perspectives in glutamate and anxiety
    Bermudo-Soriano, Carlos Riaza
    Perez-Rodriguez, M. Mercedes
    Vaquero-Lorenzo, Concepcion
    Baca-Garcia, Enrique
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 100 (04) : 752 - 774
  • [32] Development and therapeutic role of glutamate receptor antagonists.
    Leeson, PD
    Sharp, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 104 - MEDI
  • [33] Behavioral pharmacology of metabotropic glutamate 1 receptor antagonists
    De Vry, J
    Bayer, AG
    NEUROPHARMACOLOGY, 2002, 43 (02) : 284 - 284
  • [34] Pharmacodynamics of the Glutamate Receptor Antagonists in the Rat Barrel Cortex
    Vinokurova, Daria
    Zakharov, Andrey V.
    Lebedeva, Julia
    Burkhanova, Gulshat F.
    Chernova, Kseniya A.
    Lotfullina, Nailya
    Khazipov, Rustem
    Valeeva, Guzel
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [35] Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy
    Löscher, W
    PROGRESS IN NEUROBIOLOGY, 1998, 54 (06) : 721 - 741
  • [36] Combined Strategies for the Discovery of Ionotropic Glutamate Receptor Antagonists
    Chimirri, Alba
    De Luca, Laura
    Ferro, Stefania
    De Sarro, Giovanbattista
    Ciranna, Lucia
    Gitto, Rosaria
    CHEMMEDCHEM, 2009, 4 (06) : 917 - 922
  • [37] Vasopressin V1B Receptor Antagonists as Potential Antidepressants
    Chaki, Shigeyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 450 - 463
  • [38] Neurokinin-l receptor antagonists as novel antidepressants: trials and tribulations
    Hafizi, Sepehr
    Chandra, Prakash
    Cowen, Philip J.
    BRITISH JOURNAL OF PSYCHIATRY, 2007, 191 : 282 - 284
  • [39] CRF1 receptor antagonists as novel putative antidepressants and anxiolytics
    Nemeroff, CB
    Owens, MJ
    Skelton, K
    Guttman, D
    Winslow, JT
    Plotsky, PM
    BIOLOGICAL PSYCHIATRY, 2000, 47 (08) : 64S - 64S
  • [40] Structure-activity relationships of new agonists and antagonists of different metabotropic glutamate receptor subtypes
    Sekiyama, N
    Hayashi, Y
    Nakanishi, S
    Jane, DE
    Tse, HW
    Birse, EF
    Watkins, JC
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 (07) : 1493 - 1503
12345